Detailed Information
Cited 37 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Event-free survival by residual cancer burden after neoadjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for early TNBC: Exploratory analysis from KEYNOTE-522.
- Authors
- Pusztai, L[Pusztai, Lajos]; Denkert, C[Denkert, Carsten]; O'Shaughnessy, J[O'Shaughnessy, Joyce]; Cortes, J[Cortes, Javier]; Dent, RA[Dent, Rebecca Alexandra]; McArthur, HL[McArthur, Heather L.]; Kuemmel, S[Kuemmel, Sherko]; Bergh, JCS[Bergh, Jonas C. S.]; Park, YH[Park, Yeon Hee]; Hui, RN[Hui, Rina]; Harbeck, N[Harbeck, Nadia]; Takahashi, M[Takahashi, Masato]; Untch, M[Untch, Michael]; Fasching, PA[Fasching, Peter A.]; Cardoso, F[Cardoso, Fatima]; Zhu, YL[Zhu, Yalin]; Pan, W[Pan, Wilbur]; Tryfonidis, K[Tryfonidis, Konstantinos]; Schmid, P[Schmid, Peter]
- Issue Date
- 1-Jun-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.